Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
1.12 Down 0.01(0.88%) Feb 27, 4:00PM EST
|After Hours : 1.11 Down 0.01 (0.89%) Feb 27, 7:59PM EST
Add to Portfolio
Prev Close:1.13
Open:1.35
Bid:N/A
Ask:1.22 x 3500
1y Target Est:5.67
Beta:2.01
Earnings Date:Mar 9 - Mar 13 (Est.)
Day's Range:1.08 - 1.42
52wk Range:0.36 - 3.33
Volume:35,132,649
Avg Vol (3m):3,038,540
Market Cap:103.54M
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CYTXDown 0.88%103.54M
ASTM 0.00%N/A
BAXUp 0.70%37.48B
OSIRDown 0.40%592.71M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Dec-14) :-0.05
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback